ESS - APCT - Livro, parte de livro ou capítulo de livro
URI permanente para esta coleção:
Navegar
Percorrer ESS - APCT - Livro, parte de livro ou capítulo de livro por data de Publicação
A mostrar 1 - 1 de 1
Resultados por página
Opções de ordenação
- Histone posttranslational modifications and chromatin remodelers in prostate cancerPublication . Quintela Vieira, Ana Filipa; Almeida-Rios, Diogo; Pinho dos Santos Graça, Maria Inês; Henrique, Rui; Jerónimo, CarmenProstate cancer (PCa) is one of the most incident and prevalent cancers in men worldwide and a leading cause of cancer-related morbidity and mortality. Epigenetics plays an important role in prostate carcinogenesis, namely abnormal expression of histone modifier enzymes and related chromatin modifications. Notwithstanding, the limited knowledge of the specific role of deregulated activity/expression of histone modifiers and respective histone modifications hinders their use in clinical management, particularly for PCa detection and prognostication. Due to the limitations in the analysis of global patterns of histone modifications, few studies reported on the biomarker potential of these epigenetic marks. Importantly, the reversible nature of histone modifications makes them a promising therapeutic option for this malignancy. Indeed, over the past years, molecules with inhibitory activity upon the epigenetic machinery have been developed and are currently under evaluation in clinical trials to test their effectiveness.